ABT vs. OGN
Compare and contrast key facts about Abbott Laboratories (ABT) and Organon & Co. (OGN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABT or OGN.
Correlation
The correlation between ABT and OGN is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ABT vs. OGN - Performance Comparison
Key characteristics
ABT:
0.04
OGN:
-0.01
ABT:
0.19
OGN:
0.25
ABT:
1.02
OGN:
1.03
ABT:
0.03
OGN:
-0.00
ABT:
0.09
OGN:
-0.01
ABT:
8.14%
OGN:
16.60%
ABT:
17.88%
OGN:
35.79%
ABT:
-45.66%
OGN:
-69.56%
ABT:
-15.48%
OGN:
-53.32%
Fundamentals
ABT:
$196.03B
OGN:
$4.07B
ABT:
$3.29
OGN:
$5.05
ABT:
34.35
OGN:
3.13
ABT:
$30.98B
OGN:
$4.81B
ABT:
$17.29B
OGN:
$2.82B
ABT:
$7.89B
OGN:
$1.31B
Returns By Period
In the year-to-date period, ABT achieves a -0.08% return, which is significantly lower than OGN's 5.97% return.
ABT
-0.08%
-0.32%
10.55%
0.71%
6.85%
11.85%
OGN
5.97%
3.33%
-21.59%
0.28%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABT vs. OGN — Risk-Adjusted Performance Rank
ABT
OGN
ABT vs. OGN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and Organon & Co. (OGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ABT vs. OGN - Dividend Comparison
ABT's dividend yield for the trailing twelve months is around 1.98%, less than OGN's 7.08% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 1.98% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
OGN Organon & Co. | 7.08% | 7.51% | 7.77% | 4.01% | 1.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
ABT vs. OGN - Drawdown Comparison
The maximum ABT drawdown since its inception was -45.66%, smaller than the maximum OGN drawdown of -69.56%. Use the drawdown chart below to compare losses from any high point for ABT and OGN. For additional features, visit the drawdowns tool.
Volatility
ABT vs. OGN - Volatility Comparison
The current volatility for Abbott Laboratories (ABT) is 3.87%, while Organon & Co. (OGN) has a volatility of 8.12%. This indicates that ABT experiences smaller price fluctuations and is considered to be less risky than OGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ABT vs. OGN - Financials Comparison
This section allows you to compare key financial metrics between Abbott Laboratories and Organon & Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities